Lambda |
Temperate |
E. coli |
Antibiotic susceptible wild-type gene (rpsL for streptomycin/gyrA for nalixidic acid) |
Sensitize the antibiotics by complementing the antibiotic susceptible wild-type gene |
[201] |
Lambda |
Temperate |
E. coli |
CRISPR-associated genes (cas3, cse1, cse2, cas7, cas5, and cas6e) and spacer targetting ß-lactamases (ndm and ctx) |
Sensitize the antibiotics by destroying antibiotic resistance conferring plasmids |
[202] |
ФCD24-2 |
Temperate |
C. difficile |
Spacer sequence targeting bacterial chromosome |
Dual-faceted potency: CRISPR-Cas induced irreversible genomic impairment and phage lysis module mediated cellular lysis |
[203] |
M13 |
Chronic |
E. coli |
SOS response repressor, lexA3
|
Augmenting antibiotic potency by suppression of SOS response |
[205] |
T7 |
Lytic |
E. coli |
Quorum-quenching enzyme, AiiA |
Biofilm degradation by degrading acyl homoserine lactones and bactericidal effect of inherent lytic potency of T7 |
[206] |
T7 |
Lytic |
E. coli |
Biofilm detachment enzyme, DspB |
Biofilm detachment by hydrolysis of N-acetyl-D-glucosamines found in the biofilm matrices using DspB and bactericidal effect of inherent lytic potency of T7 |
[207] |
K1F |
Lytic |
E. coli |
SpyTag |
Provide versatility by tagging a variety of materials |
[208] |